Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:12 AM
NCT ID:
NCT04267120
Group ID:
EG000
Title:
Lenvatinib + Pembrolizumab
Description:
* Lenvatinib 20 mg/day will be administered orally on a daily basis and pembrolizumab 200 mg will be infused once every 3 weeks.
* Subjects may be treated with pembrolizumab for a maximum of 35 cycles or approximately 2 years, but treatment with lenvatinib can continue beyond 2 years if the subject does not meet other treatment discontinuation criteria.
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
11
Other Number Affected:
11
Other Number At Risk:
11
Study:
NCT04267120
Results Section:
NCT04267120
Adverse Events Module:
NCT04267120